This trial is concluded. This means the trial has been completed. The results of the trial are summarised in the 'outcomes' section of this page. You cannot enrol in this trial.
About this trial
We know that adherence is important for treatment success, so this study compares a once-a-day regimen with a twice-a-day one.
| Official title: | A Randomised, Multi-Centre, Open-Label Study in Well-Controlled Treatment-Experienced HIV-Infected Patients to Assess Compliance With a Once-Daily Regimen of Lamivudine, Efavirenz and Didanosine Versus Continuation of Current Anti-Retroviral Regimen Delivered at Least Twice Daily |
|---|---|
| What is this trial studying? | Existing drug |
| Start date: | May 2004 This may be the proposed or expected start date for trials which have not yet started. |
| How many participants will this trial enrol? | 120 The exact number of participants may be lower or slightly higher than this. Some trials also have specific quotas for participants from each state, city or clinic. |
| How long is this trial planned to go for? | Participants in this trial will be asked to take the trial drug for 24 weeks. Following the conclusion of the trial, participants will be followed up for a further 24 weeks. |
| Who can enrol in this trial? | You may be eligible to participate in this trial if you meet the following criteria:
|
| Links to further information: | |
| Results: | See above link for an enlightening article on 'Treatment simplification'. |
| Keywords: | adherence, didanosine, efavirenz, lamivudine |
While NAPWA has taken every care to compile the information on this page and to keep it up-to-date, we cannot guarantee its correctness and completeness.
- Before making the decision to participate in any clinical research, read our background information.
- Email NAPWA if you have any questions or comments about this trial
- Call the Treataware info line if you need further advice
This Backgrounder looks at the science behind clinical trials and the reason why controlled scientific experiments are needed to answer scientific questions.